Biocompatibility of single-walled carbon nanotube composites for bone regeneration.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4438669)

Published in Bone Joint Res on May 01, 2015

Authors

A Gupta1, T A Liberati1, S J Verhulst1, B J Main1, M H Roberts1, A G R Potty1, T K Pylawka1, S F El-Amin Iii1

Author Affiliations

1: Southern Illinois University School of Medicine, 701 N First Street, Springfield, Illinois 62794-9679, USA.

Articles cited by this

Bone substitutes: an update. Injury (2005) 4.49

Tissue-engineered bone regeneration. Nat Biotechnol (2000) 3.84

Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials (1996) 3.66

Tissue engineering: orthopedic applications. Annu Rev Biomed Eng (1999) 2.36

Surface-active biomaterials. Science (1984) 2.21

Carbon nanotubes for biomedical applications. IEEE Trans Nanobioscience (2005) 1.61

Chemically Functionalized Carbon Nanotubes as Substrates for Neuronal Growth. Nano Lett (2004) 1.58

Bio-compatibility in selection of materials for implantation. J Biomed Mater Res (1970) 1.42

Treatment of nonunions and osseous defects with bone graft and calcium sulfate. Clin Orthop Relat Res (2003) 1.40

In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res (1999) 1.30

Tissue reactions to polymers. Lancet (1962) 1.23

The importance of new processing techniques in tissue engineering. MRS Bull (1996) 1.14

Carbon nanotubes: biomaterial applications. Chem Soc Rev (2009) 1.08

In vivo biodegradability and biocompatibility evaluation of novel alanine ester based polyphosphazenes in a rat model. J Biomed Mater Res A (2006) 1.06

Tissue engineered bone-regeneration using degradable polymers: the formation of mineralized matrices. Bone (1996) 1.03

Material-tissue interfaces: the role of surface properties and processes. Environ Health Perspect (1994) 0.94

Poly (lactic-co-glycolic acid) as a controlled release delivery device. J Mater Sci Mater Med (2009) 0.92

Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials (1993) 0.90

Poly(anhydride-co-imides): in vivo biocompatibility in a rat model. Biomaterials (1998) 0.89

An update on recent advances in bone regeneration. Injury (2008) 0.89

Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res (1973) 0.86

Single walled carbon nanotube composites for bone tissue engineering. J Orthop Res (2013) 0.86

Effects of carbon nanotubes (CNTs) on the processing and in-vitro degradation of poly(DL-lactide-co-glycolide)/CNT films. J Mater Sci Mater Med (2007) 0.84

Bone formation on carbon nanotube composite. J Biomed Mater Res A (2010) 0.84

Biocompatibility of composite membrane consisting of oriented needle-like apatite and biodegradable copolymer with soft and hard tissues in rats. Dent Mater J (2004) 0.82

Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. J Biomed Mater Res (1990) 0.82

The significance of implant shape in experimental testing of biological materials: disc vs. rod. J Biomed Mater Res (1970) 0.82

Vascularized free fibular bone graft in the management of congenital tibial pseudarthrosis. Microsurgery (2009) 0.82

The foreign body reaction to a biodegradable biomaterial differs between rats and mice. J Biomed Mater Res (2000) 0.79

Subacute toxicity testing of biomaterials using histopathologic evaluation of rabbit muscle tissue. J Biomed Mater Res (1973) 0.79

In vitro evaluation of three-dimensional single-walled carbon nanotube composites for bone tissue engineering. J Biomed Mater Res A (2014) 0.77

Effect of nanotubes and apatite on growth factor release from PLLA scaffolds. J Tissue Eng Regen Med (2010) 0.77